Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
days to go:
Expired
investment:
£465,150
Gripit offers uniquely designed plasterboard fixings, which can hold tremendous loads upto 113kgs. These light weighted and easy to install products are exported to over 32 countries, thereby raising over £4m in the last Crowdcube campaigns. In 2008, Mr. Jordan Daykin invented gripit drywall anchor when he was just 13 years old. In 2014, he became the youngest person to secure investment through BBC’s Dragon Den.
days to go:
Expired
investment:
£1,007,470
An end-to-end digital platform providing aesthetic medical treatment in a market valued at almost £76bn. NowMe work closely with customers throughout the process by discussing the treatment they desire, selecting an appropriate medical practitioner from a UK Clinic and offering available finance solutions. The company is raising funds to refine their product and secure IP, as well as cover working capital requirements. The firm plan to launch in 2018 and by 2025 achieve international leadership.
days to go:
Expired
investment:
£172,790
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments.
Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go:
Expired
investment:
Withheld
Carnot is an engineering company that is developing biofuel and hydrogen-powered Carnot engines with the aim of reducing global CO2 levels by 13%. The company asserts that metal engines, unable to withstand fuel combustion temperatures, waste one-third of fuel energy to cooling & have operating efficiencies of only 30%. Carnot argues that its engines can bring operating efficiencies up to 70%, halving fuel costs. It also intends to develop clean, secure, and affordable global off-grid energy solutions and provide disruptive technologies that are both commercially viable and environmentally friendly. Carnot was awarded a £157,000 Innovate UK Grant to develop an energy access solution in Sub-Saharan Africa. It was also awarded a place on OGTC Tech X accelerator, in partnership with organisations like British Petrol (BP), Equinor, and KPMG with a £100,000 funding. The company will use the investment to bump up the maximum theoretical engine efficiency to ~85%.
days to go:
Expired
investment:
£307,911
OVD Development Ltd. owns IP rights for fluorescent products used for ophthalmic surgery, which is basically a new approach to viscoelastic medium (OVD). The goal of OVD Development Ltd. is to complete the CE marking process. Till 2017, it estimates to be worth $560 million with an expected 11.6% average annual growth in the global market.
days to go:
Expired
investment:
£82,300
Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.
days to go:
Expired
investment:
£616,916
Please watch the video for more information
days to go:
Expired
investment:
£607,175
Regenerative Medical Group provides a remedy for Wound Healing and Erectile Dysfunction (ED) by using non-invasive technology. It partners with clinics to render the service such as reception, treatment rooms and nurses. In addition to the Erectile Dysfunction (ED) market, it has identified wound healing as a new market. Currently, it is working with an experienced NHS/NICE validation team to show its value as a treatment modality. RMG reached revenues of £400k, -56k EBITDA in the financial year 2017, and is operational in 5 clinics.
days to go:
Expired
investment:
£67,740
Riversimple is a car manufacturer and service provider that is spearheading ‘next-generation’ Hydrogen electric vehicles. It sells mobility as a service and retains ownership of its cars. Their pricing structure allows customers to pay a single monthly fee that covers the vehicle, fuel, maintenance, and insurance costs. It's proprietary offering, Rasa, is a two-seat local commuter vehicle that can achieve a 250mpg equivalent fuel figure with a 300-mile range from a 3-minute fill. The company has recently been awarded two new grants from The Office for Low Emission Vehicles (OLEV) for £1.25 million to support the build of its first low volume production run, and another from InnovateUK worth £0.5 million to support the deployment of cars in the Milford Haven Energy Kingdom project. The company has also been featured in several prominent publications such as The Guardian, CNBC, BBC Wales, Reuters and CNN to name a few. The company will use the investment to expand its engineering team and start volume production to reach product commercialisation by the end of 2022.
days to go:
Expired
investment:
£504,000
